P
Power Law company profile
Polyplus-transfection
Biotech & Life Sciences · Illkirch, France · Founded 2001 Unicorn
Patent intelligence
$17M patent portfolio · 12 active families
Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.
Estimated portfolio value
$17M
0.64% of valuation · 45.8× smaller than top peer BioNTech ($780M)
12 active patent families
Where Polyplus-transfection innovates
Molecular biologyTransfectionRNA interferenceOligonucleotideRibosomal RNA Genes
Above peer median on Legal, Strategic, Market, Economic, Technology
Quality vs same-sector peers
Polyplus-transfection on the five Patsnap quality dimensions
Polyplus-transfection in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.
Compare against
Patent quality scores (0–100)
Source: Dealroom Patent Intelligence · PatsnapTech-focus vs peers
Where Polyplus-transfection concentrates inside the peer cluster
Axes are the most-shared Patsnap topics across Polyplus-transfection and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).
Compare against
Top-topic prominence (rank inverted, 0–100)
Source: Dealroom Patent Intelligence · Patsnap top-10 topics per companySee Polyplus-transfection on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.